GSK plc
corporate_fare Company Profile
GSK plc (NYSE:GSK) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 65 items for GSK at importance 7 or higher on its 1–10 market-impact scale.
Recent high-impact activity:
- GSK Completes $950M Acquisition of 35Pharma, Adding Pulmonary Hypertension Drug HS235
- GSK's Novel ADC Shows Strong Phase 1 Efficacy in Gynaecological Cancers, Advances to Five Pivotal Phase 3 Trials
- GSK's Exdensur Approved in China for Chronic Rhinosinusitis with Nasal Polyps
- GSK's ViiV Healthcare Completes Shareholding Restructuring, Pfizer Exits
- GSK's Bepirovirsen NDA Accepted for Review in China for Chronic Hepatitis B
Financial Snapshot
Insider Transactions
GSK files as a Foreign Private Issuer (FPI). Under SEC Exchange Act Section 16(a), officers, directors, and 10% owners of FPIs are exempt from Form 4 insider-transaction reporting requirements. Comparable disclosures, when applicable, appear in the company's Form 20-F (annual) or Form 6-K (interim) filings on SEC EDGAR.